{"id":229966,"date":"2025-10-21T12:58:07","date_gmt":"2025-10-21T12:58:07","guid":{"rendered":"https:\/\/www.newsbeep.com\/au\/229966\/"},"modified":"2025-10-21T12:58:07","modified_gmt":"2025-10-21T12:58:07","slug":"researchers-develop-a-new-approach-for-treating-children-with-neuroblastoma","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/au\/229966\/","title":{"rendered":"Researchers develop a new approach for treating children with neuroblastoma"},"content":{"rendered":"<p>A research team from the University of Zurich and the University Children&#8217;s Hospital Zurich has developed a new approach for treating children with malignant tumors of the nervous system. By combining an approved drug with a specialized diet, they were able to slow down tumor growth and stimulate cancer cells to mature into normal nerve cells.<\/p>\n<p>Neuroblastomas are malignant tumors of the <a href=\"https:\/\/www.news-medical.net\/health\/What-is-the-Nervous-System.aspx\" class=\"linked-term\" rel=\"nofollow noopener\" target=\"_blank\">nervous system<\/a> and rank among the most common and aggressive solid tumors in children. Most affected children are younger than five years of age. Particularly in high-risk neuroblastoma, the prognosis remains poor despite intensive treatment, with only half of children being cured.<\/p>\n<p>Effects of drug boosted<\/p>\n<p>A research team led by Raphael Morscher, research group leader and attending physician at the University of Zurich (UZH) and the University Children&#8217;s Hospital Zurich, has now developed a novel therapeutic approach together with international partners. The researchers focused on a drug-diet combination with difluoromethylornithine (DFMO), a drug recently approved in Switzerland. DFMO inhibits the production of so-called polyamines, which play a key role in tumor cell growth in children.<\/p>\n<p>&#13;<\/p>\n<p>We discovered that the effectiveness of DFMO can be more than doubled in mice when a targeted, proline- and arginine-free diet is applied under controlled conditions.&#8221;<\/p>\n<p>&#13;<br \/>\n&#13;<\/p>\n<p style=\"text-align: right;\">Raphael Morscher, research group leader and attending physician at the University of Zurich (UZH) and the University Children&#8217;s Hospital Zurich<\/p>\n<p>&#13;<\/p>\n<p>The diet amplifies the drug&#8217;s effects by additionally blocking the formation of polyamine precursors.<\/p>\n<p>Reprogramming cancer cells<\/p>\n<p>Rather than destroying the cancer cells, the treatment drives them to mature. This puts a stop to the tumor&#8217;s unrestrained cell division, and the cells begin to transform into more mature nerve cells &#8211; a natural process that is blocked in neuroblastoma.<\/p>\n<p>&#8220;The treatment not only slows down tumor growth but also brings about a functional change in the cancer cells,&#8221; says Morscher, describing the new therapeutic approach. In the pre-clinical mouse models, the tumors grew significantly more slowly or even regressed &#8211; and the treatment was well tolerated. It targets protein production in cancer cells by preventing specific genetic blueprints from being correctly read and translated. This changes the cells&#8217; function and promotes the maturation of the cancer cells.<\/p>\n<p>Enzyme replaces diet<\/p>\n<p>Raphael Morscher&#8217;s research team is now collaborating with international partners at the Children&#8217;s Hospital of Philadelphia and Princeton University to prepare the therapy for clinical application. &#8220;To bring this innovative approach into clinical trials, we are using an enzyme that replaces the diet in children. Our goal is to offer affected children a new and gentler treatment option in the future,&#8221; says Morscher.<\/p>\n<p>\u00a0<\/p>\n<p>Source:<\/p>\n<p>Journal reference:<\/p>\n<p>Cherkaoui, S., et al. (2025). Reprogramming neuroblastoma by diet-enhanced polyamine depletion.\u00a0Nature. <a href=\"https:\/\/doi.org\/10.1038\/s41586-025-09564-0\" rel=\"noopener nofollow\" target=\"_blank\">doi.org\/10.1038\/s41586-025-09564-0<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"A research team from the University of Zurich and the University Children&#8217;s Hospital Zurich has developed a new&hellip;\n","protected":false},"author":2,"featured_media":15209,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[64,63,1617,99474,1618,502,1298,41267,4082,54563,11749,12890,135841,337,105,39080,4393],"class_list":["post-229966","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-au","tag-australia","tag-cancer","tag-cancer-therapy","tag-cell","tag-children","tag-diet","tag-enzyme","tag-hospital","tag-malignant","tag-nerve","tag-nervous-system","tag-neuroblastoma","tag-research","tag-technology","tag-therapy","tag-tumor"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/229966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=229966"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/229966\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/15209"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=229966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=229966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=229966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}